HomeAbout

TL;DR CNBC


Pfizer to price Covid drug Paxlovid at $1,390 per course - TL;DR CNBC

Pfizer to price Covid drug Paxlovid at $1,390 per course

Publishing timestamp: 2023-10-18 21:39:26


Summary

Pfizer will price its Covid antiviral drug Paxlovid at $1390 for a five-day course when it starts selling it on the commercial market later this year. However, health insurance plans are expected to pay much less than the list price, meaning patients will likely have small or no out-of-pocket costs. The price has raised concerns about access to the treatment, but Pfizer is working with payers to lower copays and ensure broad and equitable access. Pfizer also expects lower revenue from Paxlovid due to the return of doses labeled for emergency use.


Sentiment: POSITIVE

Tickers: PFE

Keywords: health care industrybusinesspharmaceuticalsbiotech and pharmaceuticalspfizer inccoronavirusbusiness newsbiotechnology

Source: https://www.cnbc.com/2023/10/18/pfizer-to-price-covid-drug-paxlovid-at-1390-per-course-.html


Developed by Leo Phan